TY - JOUR
T1 - Metabolic syndrome across Europe
T2 - Different clusters of risk factors
AU - Scuteri, Angelo
AU - Laurent, Stephane
AU - Cucca, Francesco
AU - Cockcroft, John
AU - Cunha, Pedro Guimaraes
AU - Mañas, Leocadio Rodriguez
AU - Raso, Francesco U Mattace
AU - Muiesan, Maria Lorenza
AU - Ryliškyte, Ligita
AU - Rietzschel, Ernst
AU - Strait, James
AU - Vlachopoulos, Charalambos
AU - Völzke, Henry
AU - Lakatta, Edward G.
AU - Nilsson, Peter M.
PY - 2015/4/15
Y1 - 2015/4/15
N2 - Background: Metabolic syndrome (MetS) remains a controversial entity. Specific clusters of MetS components - rather than MetS per se - are associated with accelerated arterial ageing and with cardiovascular (CV) events. To investigate whether the distribution of clusters of MetS components differed cross-culturally, we studied 34,821 subjects from 12 cohorts from 10 European countries and one cohort from the USA in the MARE (Metabolic syndrome and Arteries REsearch) Consortium. Methods: In accordance with the ATP III criteria, MetS was defined as an alteration three or more of the following five components: elevated glucose (G), fasting glucose ≥110 mg/dl; low HDL cholesterol, 102 cm for men or >88 cm for women. Results: MetS had a 24.3% prevalence (8468 subjects: 23.9% in men vs. 24.6% in women, p
AB - Background: Metabolic syndrome (MetS) remains a controversial entity. Specific clusters of MetS components - rather than MetS per se - are associated with accelerated arterial ageing and with cardiovascular (CV) events. To investigate whether the distribution of clusters of MetS components differed cross-culturally, we studied 34,821 subjects from 12 cohorts from 10 European countries and one cohort from the USA in the MARE (Metabolic syndrome and Arteries REsearch) Consortium. Methods: In accordance with the ATP III criteria, MetS was defined as an alteration three or more of the following five components: elevated glucose (G), fasting glucose ≥110 mg/dl; low HDL cholesterol, 102 cm for men or >88 cm for women. Results: MetS had a 24.3% prevalence (8468 subjects: 23.9% in men vs. 24.6% in women, p
KW - Blood pressure
KW - epidemiology
KW - Europe
KW - glucose
KW - HDL cholesterol
KW - metabolic syndrome
KW - triglycerides
KW - waist circumference
UR - http://www.scopus.com/inward/record.url?scp=84924968884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924968884&partnerID=8YFLogxK
U2 - 10.1177/2047487314525529
DO - 10.1177/2047487314525529
M3 - Article
C2 - 24647805
AN - SCOPUS:84924968884
VL - 22
SP - 486
EP - 491
JO - European Journal of Preventive Cardiology
JF - European Journal of Preventive Cardiology
SN - 2047-4873
IS - 4
ER -